International Stem Cell (ISCO) EBITDA Margin (QoQ) (2010 - 2025)
International Stem Cell (ISCO) EBITDA Margin (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,849.00 |
| Sep 30, 2025 | -286.00 |
| Jun 30, 2025 | 1,692.00 |
| Mar 31, 2025 | -1,218.00 |
| Dec 31, 2024 | 622.00 |
| Sep 30, 2024 | -1,052.00 |
| Jun 30, 2024 | 1,475.00 |
| Mar 31, 2024 | 1,409.00 |
| Dec 31, 2023 | -1,753.00 |
| Sep 30, 2023 | 291.00 |
| Jun 30, 2023 | -792.00 |
| Mar 31, 2023 | -241.00 |
| Dec 31, 2022 | 2,013.00 |
| Sep 30, 2022 | -1,915.00 |
| Jun 30, 2022 | 29.00 |
| Mar 31, 2022 | 1,876.00 |
| Dec 31, 2021 | 1,630.00 |
| Sep 30, 2021 | -1,167.00 |
| Jun 30, 2021 | 1,205.00 |
| Mar 31, 2021 | 1,546.00 |